UFIS-SWE-IG
0.1.0 - ci-build
UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions
Full name: Zinacef 750 mg Pulver till injektions-/infusionsvätska, lösning
- Invented name part: Zinacef
- Strength part: 750 mg
- Pharmaceutical dose form part: Pulver till injektions-/infusionsvätska, lösning
Name usage: Swedish (Kingdom of Sweden)
Authorised dose form: Powder for solution for injection/infusion
Legal status of supply: Medicinal product subject to medical prescription
Domain: Human use
Resource status: Current
Product classification:
Marketing Authorisation 1 of 1
Authorisation number: 50971
Region: Kingdom of Sweden
Marketing authorisation holder: Sandoz A/S
Identifier:
Status: Valid (2015-03-19)
Package 1 of 1
PCID:
Description: Injektionsflaska, 5 st (5 x 750 mg)
Marketing status:
Pack size:
Package: 1 Box (Plastic)
Containing:
Package: 5 Box (Cardboard)
Containing:
Package: 1 Vial (Glass)
Containing: 1 Vial
Manufactured Item
Dose form: Powder for solution for injection/infusion
Unit of presentation: Vial
Ingredient
Role: Active
Substance: cefuroxime sodium
Concentration strength: 789 milligram(s) / 1 unit(s)
Reference strength: cefuroxime 750 milligram(s) / 1 unit(s)
Administrable Product (1 of 1)
Dose form: Solution for injection/infusion
Unit of presentation:
Route of administration:
Ingredient
Role: Active
Substance: cefuroxime sodium
Concentration strength: 789 milligram(s) / 1 unit(s)
Reference strength: cefuroxime 750 milligram(s) / 1 unit(s)